SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending following its Q4 earnings, where an adjusted EBITDA miss and persistent scrutiny over its accounting practices and reliance on loan sales have intensified bearish sentiment. The community is sharply divided, with many calling it a 'scam' while others anticipate potential short squeezes or buying activity on the dip amid high volatility.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart's robust quarterly performance is currently overshadowed by a cautious long-term profit outlook, sparking extensive community debate over its elevated valuation. Investors are actively discussing whether the conservative guidance signals broader economic pressures or is offset by the company's new share repurchase program and increased dividend.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is a major talking point ahead of its upcoming earnings, with the community weighing strategic tech integrations and a potential credit card rate cap against ongoing lawsuits and a significant insider share lock-up expiration.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending after reporting better-than-expected financial results and strong future guidance, challenging the narrative that AI will replace traditional software. This strong performance is leading many in the community to believe the stock is undervalued and fueling speculation about a potential short squeeze.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is experiencing significant momentum after its ANKTIVA bladder cancer therapy received European Commission authorization, sparking widespread community enthusiasm for its global expansion and broader therapeutic potential, amid mounting speculation of a short squeeze.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending on the back of its strong earnings report, revealing record revenue and treasury, which is driving community optimism for significant growth amid ongoing discussions about undervaluation and market dynamics in the silver sector.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

DoorDash is trending as shares surged following its latest earnings report, which, despite mixed financials, highlighted strong Gross Order Volume and strategic investments in growth and AI partnerships. However, community sentiment remains split, with some celebrating its long-term potential and insider confidence, while others question its high valuation and the sustainability of consumer demand amidst broader economic pressures and regulatory scrutiny.

Etsy, Inc. engages in the operation of an online marketplace. It offers handmade products such as shoes, clothing, bags, and accessories. It operates through the following segments: Etsy, Reverb, and Depop. The company was founded in 2005 and is headquartered in New York, NY.

Etsy Inc

Etsy is surging after reporting strong Q4 earnings and authorizing a significant share buyback, alongside the strategic sale of its Depop marketplace to eBay for $1.2 billion. The community is actively debating whether this divestment is a smart move to refocus on its core business or a loss given the original acquisition cost, fueling conversation around the company's future direction in the evolving e-commerce landscape.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals trends following recent earnings that revealed strong Rezdiffra sales, which the community hails as a blockbuster for MASH treatment. Investors are actively debating the company's strategic licensing of new programs, with some viewing it as an aggressive move to dominate the MASH market while others express concerns about expenses and a focus on profitability, intensifying ongoing buyout speculation.

B2Gold Corp. is an exploration company, which engages in the acquisition and development of mineral properties. It operates through the following segments: Fekola Mine, Fekola Regional, Masbate Mine, Otjikoto Mine, Goose Project, Other Mineral Properties, and Corporate and Other. The Fekola Regional segment consists of Bantako North, Menankoto, Dandoko, and Bakolobi properties. The Other Mineral Properties segment focuses on the company interests in mineral properties which are at various stages of exploration and evaluation. The Corporate and Other segment includes the corporate operations. The company was founded by Mark Anthony Corra, Thomas A. Garagan, Clive Thomas Johnson, and Roger Thomas Richer on November 30, 2006 and is headquartered in Vancouver, Canada.

B2gold Corp

B2Gold Corp. is trending after releasing mixed Q4 2025 results and 2026 guidance, reporting record annual revenue but missing analyst earnings expectations. This, coupled with a notable increase in projected All-In Sustaining Costs, has ignited a divided community discussion regarding management's performance and the stock's valuation amid strong gold prices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BioAge Labs (NASDAQ:BIOA) Shares Gap Up - Time to Buy?

BioAge Labs (NASDAQ:BIOA) Shares Gap Up - What's Next...

BioAge Labs, Inc. (NASDAQ:BIOA) Given Consensus Rating of "Hold" by Analysts

BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) has been assigned an average recommendation of "Hold" from the three analysts that are currently covering the stock, MarketBeat reports. One equities...

BioAge Labs, Inc. (NASDAQ:BIOA) Short Interest Down 16.3% in January

BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) was the target of a large drop in short interest during the month of January. As of January 30th, there was short interest totaling 909,129 shares, a...

BioAge Labs (NASDAQ:BIOA) Trading Down 5.6% - Here's What Happened

BioAge Labs (NASDAQ:BIOA) Trading Down 5.6% - Here's Why...

BLA for subcutaneous formulation of Leqembi designated for Priority Review in China

BLA for subcutaneous formulation of Leqembi designated for Priority Review in China BLA for subcutaneous formulation of Leqembi designated for Priority Review in China PR Newswire STOCKHOLM, Feb. 9...

BioAge Labs (NASDAQ:BIOA) Insider Sells $139,368.75 in Stock

BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) insider Paul Rubin sold 7,433 shares of the firm's stock in a transaction that occurred on Monday, February 2nd. The stock was sold at an average...

BioAge Labs (NASDAQ:BIOA) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of BioAge Labs from a "sell" rating to a "hold" rating in a report on Tuesday...

BioAge Labs (NASDAQ:BIOA) Downgraded to Sell Rating by Wall Street Zen

Wall Street Zen lowered shares of BioAge Labs from a "hold" rating to a "sell" rating in a research note on Monday...

BioAge Labs (NASDAQ:BIOA) Stock Price Down 4.1% - Here's What Happened

BioAge Labs (NASDAQ:BIOA) Stock Price Down 4.1% - Here's Why...

BioAge Labs (NASDAQ:BIOA) Shares Gap Down - Time to Sell?

BioAge Labs (NASDAQ:BIOA) Shares Gap Down - Here's What Happened...

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Emeryville, CA.

BioAge Labs Inc.

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $WMT earnings on Thursday?

BIOA
BioAge Labs Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BIOA News

BIOABioAge Labs Inc.